The Glenway Health Plan's pharmacy and therapeutics (P&T) committee conducted pharmacoeconomic research to measure both the clinical outcomes and costs of two new cholesterol-reducing drugs. Results were presented as a ratio showing the cost required to produce a 1 mcg/l decrease in cholesterol levels. The type of pharmacoeconomic research that Glenway conducted in this situation was most likely
Catalina
11 months agoSina
11 months agoBeckie
11 months agoJulio
11 months agoSol
11 months agoIzetta
12 months agoLettie
12 months agoAllene
12 months ago